L&C Bio CEO Lee Whan Chul sees the company's new product addressing the hollow cheeks and sagging skin known as "Ozempic face” in GLP-1 users. | REUTERS
Aug 6, 2026
“Ozempic face” could spawn the next K-beauty craze. South Korean biotech L&C Bio plans to launch an injectable skin booster made from donated human fat to restore lost facial volume, betting demand for cosmetic fixes tied to blockbuster weight-loss drugs will drive its next phase of growth.
L&C — which pioneered the use of donated human tissue in K-beauty skin boosters — developed the technology about five years ago, CEO Lee Whan Chul said in an interview. The company holds patents on the technology in South Korea, the U.S. and China.
South Korea has repeatedly turned niche cosmetic procedures into global beauty trends, from glass skin regimens to salmon sperm facials and L&C’s flagship human tissue treatment Re2O. The next wave may shift from improving skin quality to restoring facial and body volume, which L&C Bio’s new product is designed to support.
In a time of both misinformation and too much information,
quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.
SUBSCRIBE NOW
